Previous Close | 6.93 |
Open | 8.20 |
Bid | 8.80 x 800 |
Ask | 8.83 x 800 |
Day's Range | 7.96 - 9.02 |
52 Week Range | 3.06 - 9.02 |
Volume | |
Avg. Volume | 2,752,553 |
Market Cap | 2.042B |
Beta (5Y Monthly) | 0.43 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.13 |
Earnings Date | Aug 07, 2024 - Aug 12, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 8.38 |
ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2024 Earnings Call Transcript May 9, 2024 ADMA Biologics, Inc. beats earnings expectations. Reported EPS is $0.07532, expectations were $0.05. ADMA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome to the […]
Robust Growth and Upward Financial Guidance Highlight a Strong Quarter
Adma Biologics (ADMA) delivered earnings and revenue surprises of 60% and 6.75%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?